US FDA Would Get Funding Boost Under House Coronavirus Stimulus Bill
Agency appears to have a fair bit of flexibility in how to spend the additional $80m slated for coronavirus activities.
You may also be interested in...
Unlike diagnostics, EUAs for drugs are rare and the fact that there already are FDA-approved competitors for Bayer’s chloroquine phosphate product may make the decision more complicated.
Screenings at ports of entry may be modified, but the drug supply remains safe and secure, Stephen Hahn tells House Committee, arguing that other tools will allow for continued facility policing during the coronavirus outbreak even if the absence of inspections.
US CDC influenza official says that capacity is not an issue, since the system is already scaled for a pandemic, but a key will be availability of testing to distinguish the viruses.